CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 21, 2014 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,745 Total Citation Count
- Mar 31, 1994 Earliest Filing
- 13 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7495085 Antibodies against human or mouse IL-21 receptorExpiredMar 12, 04Feb 24, 09[A61K, C12P, C07K]
2008/0194,475 Erythropoietin Protein VariantsAbandonedApr 22, 05Aug 14, 08[A61K, C12Q, C12P, C12N, C07K]
2007/0298,034 SULFOTYROSINE SPECIFIC ANTIBODIES AND USES THEREFORAbandonedDec 08, 06Dec 27, 07[A61K, C07H, C12P, C12N, G01N, C07K]
2007/0298,430 Ribosome Display or Mrna Display Method With Selection for Increased Stability of the ProteinAbandonedJan 05, 06Dec 27, 07[C12Q, C12P, C07K]
7306907 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptorsExpiredNov 08, 02Dec 11, 07[C12Q]
2007/0232,790 PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGEAbandonedJan 22, 07Oct 04, 07[C07K]
2007/0160,601 NEUTRALIZING ANTIBODIES AGAINST PRIMATE PSGL-1 AND USES THEREFORAbandonedDec 08, 06Jul 12, 07[A61K, C07H, C12P, C12N, C07K]
5977319 Specific binding members for estradiol; materials and methodsExpiredOct 21, 97Nov 02, 99[A61K, C07K]
5958411 Methods of inhibiting ECM accumulation in the CNS by inhibition of TGF-.beta.ExpiredMar 24, 95Sep 28, 99[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.